M. ERDOĞAN Et Al. , "Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.5, pp.1381-1385, 2019
ERDOĞAN, M. Et Al. 2019. Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.5 , 1381-1385.
ERDOĞAN, M., Ozbek, M., Akbal, E., & Ureten, K., (2019). Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.5, 1381-1385.
ERDOĞAN, MEHMET Et Al. "Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.5, 1381-1385, 2019
ERDOĞAN, MEHMET Et Al. "Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.5, pp.1381-1385, 2019
ERDOĞAN, M. Et Al. (2019) . "Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.5, pp.1381-1385.
@article{article, author={MEHMET ERDOĞAN Et Al. }, title={Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2019, pages={1381-1385} }